Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06979648
NA

Effectiveness of Qualia Magnesium+® Supplementation on RBC Magnesium Levels

Sponsor: Qualia Life Sciences

View on ClinicalTrials.gov

Summary

This is a randomized, double-blind, placebo-controlled parallel trial designed to evaluate the effectiveness of Qualia Magnesium+® supplementation on red blood cell (RBC) magnesium levels in adults aged 21 and older. Approximately 100 participants with baseline RBC magnesium levels below 6.0 mg/dL will be randomly assigned to receive either Qualia Magnesium+ or a placebo. Participants will take 2 capsules daily in the evening, with or without food, for a duration of 12 weeks. The primary outcome is the between-group change in RBC magnesium levels from baseline to Week 12. Secondary outcomes include assessments of sleep quality, perceived stress, magnesium status, and safety and tolerability. Data collection will occur through lab bloodwork and electronic questionnaires.

Official title: Effectiveness of Qualia Magnesium+® Supplementation on RBC Magnesium Levels: A Randomized Double-Blind Parallel Trial

Key Details

Gender

All

Age Range

21 Years - Any

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2025-05-21

Completion Date

2025-09-21

Last Updated

2025-05-20

Healthy Volunteers

Yes

Interventions

DIETARY_SUPPLEMENT

Qualia Magnesium+®

Qualia Magnesium+® manufactured by Qualia Life Sciences

DIETARY_SUPPLEMENT

Placebo

Rice Flour

Locations (1)

Qualia Life Sciences

Carlsbad, California, United States